Alvogen plans to fight a court decision that could significantly delay its ability to bring a generic version of Bausch ...

Chinese biotech HuidaGene reports early success with first CRISPR brain treatment in 9-year-old with MECP2 duplication ...

Gilead's antibody-drug conjugate Trodelvy combined with Merck's Keytruda reduced the risk of disease progression or death in ...

Roivant is changing its strategy for Immunovant roughly a month after its subsidiary decided it wouldn’t take one of its ...

The FDA made two de­ci­sions on Re­gen­eron’s best-sell­ing drugs Fri­day, hand­ing down one ap­proval and one re­jec­tion.

The 340B drug discount program may move under the purview of CMS, according to a leaked HHS restructuring document reviewed ...

US brand-name drugs use foreign ingredients, with Europe supplying 43% of APIs, as Trump administration considers 25% tariffs ...

A US trade probe into pharmaceuticals is underway. And it’s hitting many of the key aspects of the supply chain.

The government is fighting in court for a plan to cut spending on overhead research costs for grantees. Primate centers fear ...

The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the ...

A hot antibody discovery team in China has signed its second US biotech deal in less than six months, marking the latest sign ...

European regulators on Tuesday authorized the use of Biogen and Eisai’s Alzheimer’s treatment Leqembi for some early-stage ...